dr rahul anand yadav md dm neonatology hod kkcth
play

DR.RAHUL ANAND YADAV MD DM(NEONATOLOGY) HOD KKCTH When to us use? - PowerPoint PPT Presentation

DR.RAHUL ANAND YADAV MD DM(NEONATOLOGY) HOD KKCTH When to us use? Whic ich type of se seiz izur ures? es? How much(d (dose ose of d drug) g) to us use? Ho How lo long g to us use? MANDAN MISHRA SANKARACHA CHARY


  1. DR.RAHUL ANAND YADAV MD DM(NEONATOLOGY) HOD KKCTH

  2.  When to us use?  Whic ich type of se seiz izur ures? es?  How much(d (dose ose of d drug) g) to us use?  Ho How lo long g to us use?

  3. MANDAN MISHRA SANKARACHA CHARY RYA

  4. 1)Eye witness 2)Logic 3)Guidelines by authority in subject

  5.  Normal Neonatal Brain  Neonatal convulsions  Drug Action  Conclusions

  6.  Disturbed balance between excitatory and inhibitory neurotransmitters  Excitatory:Glutamat e Gaba  Inhibitory:Gaba Glutamate tamate

  7.  Subtle seizures  Multi focal clonic  Generalized tonic  Myoclonic

  8.  Signal al to noise ratio  SV2A 2A agonist ist • Synaptotagmin is a calcium • Depends upon levels of sensor for exocytosis in pre cytosolic calcium levels. synaptic vesicle leading to excitatory NT release into • When cytosolic calcium levels synaptic junction. are high, signal to noise ratio is altered resulting in • SV2A regulates the activity of seizures. synaptotagmin leading to inhibition of calcium mediated • Levetiracetam inhibits the exocytosis. release and influx of calcium into cytosol thereby reducing • Levetiracetam acts as an the signal to noise ratio agonist of synaptic vesicle protein 2A

  9.  Can be used in neonates  Do not use in subtle and generalized tonic seizures  “Use in Myocloni onic seizur ures, es, especi cial ally ly stimulus ulus sen ensi siti tive ve thalamocort mocortical ical myoclonus onus ”

  10. “DOES NOT EXIST”

  11.  When to use?  Which type of seizure to use?  How much to use?  How long to use?

  12. Status NOT EPILEPSY LEVETIRACET DIAZEPAM 4 hours Epilepticu AM RISK REDUCED s

  13. LEVETIRACETAM PHENOBARBITONE  Respiratory depressant  Respiratory depressant action present action absent  Myocardial depressant  Myocardial depressant action present action absent  Metabolic  Metabolic demand:? demand:Decreased  Multifocal clonic  Multifocal clonic seizure:useful seizure:use unknown  Myocl clonic onic: less useful  Myocloni clonic: c:more more useful ul  Drug interact ractions ions  Drug g interac acti tions ons present ent ab absent ent

  14.  Liver dysfunction  Liver dysfunction absent present  In instances where  In instances where there is increased there is increased levels of ammonia,it is levels of ammonia,it is safe unsafe  Pharmacoresistance  Pharmacoresistance not seen(MDR protein) seen LEV EVETIR ETIRAC ACETA ETAM VALPR LPROAT OATE

  15.  Loading dose :40mg/kg(some units start with 20mg/kg)  1cc=100mg…  “Accidental overdose reported but non fatal!”  Maintainance dose < 7 days-10mg/kg q8h > 7 days-20mg/kg q12h  Can use higher doses in exceptional circumstances

  16.  Dentate gyrus is a part of Hippocampus  Involved in episodic memory formation and exploration of new environment  LEV ,on prolonged use has potential side effects due to effect on dentate gyrus  Manifestations include Hyperactivity,psychosis ,tremors

  17.  Routinely don’t use  Can be used in stimulus sensitive myoclonic convulsions  Higher doses tolerated better  Stop as soon as primary etiology is better

Recommend


More recommend